Skip to main content

Using LOCAMETZ

References: 1. Hofman MS, Lawrentschuk N, Francis RJ, et al. Prostate-specific membrane antigen PET-CT in patients with high-risk prostate cancer before curative-intent surgery or radiotherapy (proPSMA): a prospective, randomised, multi-centre study. Lancet. 2020;395(10231):1208-1216. doi:10.1016/S0140-6736(20)30314-7 2. Fendler WP, Eiber M, Beheshti M, et al. 68Ga-PSMA PET/CT: Joint EANM and SNMMI procedure guideline for prostate cancer imaging: version 1.0. Eur J Nucl Med Mol Imaging. 2017;44(6):1014-1024. doi:10.1007/s00259-017-3670-z 3. Locametz. Prescribing information. Novartis Pharmaceuticals Corp.